4//SEC Filing
KANGO SUJAY 4
Accession 0001179110-21-008949
CIK 0001280600other
Filed
Sep 26, 8:00 PM ET
Accepted
Sep 27, 7:21 PM ET
Size
8.3 KB
Accession
0001179110-21-008949
Insider Transaction Report
Form 4
KANGO SUJAY
SVP, Chief Commercial Officer
Transactions
- Exercise/Conversion
Option to Purchase Common Stock
2021-09-27−5,000→ 25,000 totalExercise: $40.61Exp: 2028-03-01→ Common Stock (5,000 underlying) - Sale
Common Stock
2021-09-27$175.00/sh−5,000$875,000→ 18,509 total - Exercise/Conversion
Common Stock
2021-09-27$40.61/sh+5,000$203,050→ 23,509 total
Footnotes (2)
- [F1]The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The shares of common stock underlying this stock option award vested as to 25% of the shares on the first anniversary of February 12, 2018 and the remaining shares vest in equal quarterly installments over the following three years thereafter.
Documents
Issuer
ACCELERON PHARMA INC
CIK 0001280600
Entity typeother
Related Parties
1- filerCIK 0001336503
Filing Metadata
- Form type
- 4
- Filed
- Sep 26, 8:00 PM ET
- Accepted
- Sep 27, 7:21 PM ET
- Size
- 8.3 KB